KB-0742 hydrochloride is a potent, selective and orally activeCDK9inhibitor with anIC50of 6 nM forCDK9/cyclin T1. KB-0742 hydrochloride is selective forCDK9/cyclin T1with >50-fold selectivity overotherCDK kinases. KB-0742 hydrochloride has potent anti-tumor activity[1].
References:
[1].Freeman DB, et al. Discovery of KB-0742, a Potent, Selective, Orally Bioavailable Small Molecule Inhibitor of CDK9 for MYC-Dependent Cancers. J Med Chem. 2023 Dec 14;66(23):15629-15647.
















